Antiphospholipid antibody syndrome

Hemocoagulative Problems in the Critically Ill Patient

Volumn 9788847024489, Issue , 2012, Pages 209-216

  Zambon, Marco ^a   Cappelli, Davide ^a   Berlot, Giorgio ^a  

^a UNIVERSITY OF TRIESTE   (Italy)

Author keywords

Antibody; Antiphospholipid; Antiphospholipid antibodies; Syndrome; Thrombosis

Indexed keywords

EID: 84885626855     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-88-470-2448-9_13     Document Type: Chapter

References (55)

1. Wassermann A, Neisser A, Bruck C (1906) Eine serodiagnostische reaction bei Syphilis. Dtsch Med Wochenschr 32:745-746
2. Matsuura E, Igasrashi Y, Fujimoto M et al (1992) Heterogeneity of anticardiolipin antobodies defined by anticardiolipin cofactor. J Immunol 144:3885-3891
3. Forestiero RR, Martinuzzo ME, Kordich LC, Carreras LO (1996) Reactivity to b2-glycoprotein I clearly differentiates anticardiolipin antibodies from anti-phospholipid syndrome and syphilis. Thromb Haemost 75:717-720
4. Triplett DA (2002) Antiphospholipid antibodies. Arch Pathol Lab Med 126:1424-1429
5. Brandt JT, Triplett DA, Alving B, Scharrer I (1995) Criteria for the diagnosis of lupus anticoagulants: an update. Thromb Haemost 74:1185-1190
6. Tripodi A, Chantarangkul V, Clerici M et al (2002) Laboratory diagnosis of lupus anticoagulant treatment. Performance of dilute Russell viper venom test and silica clotting time in comparison with Staclot LA. Thromb Haemost 88:583-586
7. Harris EN, Pierangeli SS (2002) Revisiting the anticardiolipin test and its standardization. Lupus 11:269-275
8. Harris EN (1990) Special report: the second international anti-cardiolipin standardization workshop/the Kingston Anti-Phospholipid Antibody Study (KAPS) group. Am J Clin Pathol 94:476-484
9. Long AA, Ginsberg JS, Brill-Edwards P et al (1991) The relationship of antiphospholipid antibodies to thromboembolic disease in systemic lupus erythematosus: a cross-sectional study. Thromb Haemost 66:520-524
10. Galli M, Luciani D, Bertolini G, Barbui T (2003) Anti-beta 2-glycoprotein I, antiprothrombin antibodies, and the risk of thrombosis in the antiphospholipid syndrome. Blood 102:2717-2723
11. de Groot PG, Horbach DA, Simmelink MJ et al (1998) Anti-prothrombin antibodies and their ralation with thrombosis and lupus anticoagulant. Lupus 7(Suppl 2):S32-S36
12. Satoh A, Suzuki K, Takayama E et al (1999) Detection of anti-annexin IV and V antibodies in patients with antiphospholipid syndrome and systemic lupus erythematosus. J Rheumatol 26:1715-1720
13. de Groot PG, Derksen RH (2005) Pathophysiology of the antiphospholipid syndrome. J Thromb Haemost 3:1854-1860
14. Hemker HC, Dieri RA, De Smedt E, Béguin S (2006) Thrombin generation, a function test of the haemostatic-thrombotic system. Thromb Haemost 96:553-561
15. Membre A, Wahl D, Latger-Cannard V et al (2008) The effect of platelet activation on the hypercoagulability induced by murine monoclonal antiphospholipid antibodies. Haematologica 93:566-573
16. Vila P, Hernandez MC, Lopez-Fernandez MF et al (1994) Prevalence, follow-up and clinical significance of the anticardiolipin antibodies in normal subjects. Thromb Haemost 72:209-213
17. Ginsberg JS, Wells PS, Brill-Edwards P et al (1995) Antiphospholipid antibodies and venous thromboembolism. Blood 86:3685-3691
18. Mateo J, Oliver A, Borrell M et al (1997) Laboratory evaluation and clinical characteristic of 2, 132 consecutive unselected patients with venous thromboembolism: results of the Spanish multicentric study on thrombophilia (EMET-study). Thromb Haemost 77:444-451
19. Galli M, Luciani D, Bertolini G et al (2003) Lupus anticoagulants are stronger risk factor for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature. Blood 101:1827-1832
20. Wilson WA, Gharavi AE, Koike T et al (1999) International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 42:1309-1311
21. Miyakis S, Lockshin MD, Atsumi T et al (2006) International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 4:295-306
22. Tincani A, Allegri F, Sanmarco M et al (2001) Anticardiolipin antibody assay: a methodological analysis for a better consensus in routine determinations: a cooperative project of the European antiphospholipid forum. Thromb Haemost 86:575-583
23. Brandt JT, Barna LK, Triplett DA (1995) Laboratory identification of lupus anticoagulants: results of the second international workshop for identification of lupus anticoagulants. Thromb Haemost 74:1597-1603
24. Asherson RA (1992) The catastrophic antiphospholipid syndrome. J Rheumatol 19:508-512
25. Bucciarelli S, Espinosa G, Cervera R et al (2006) For the CAPS registry project group (european forumon antiphospholipid antibodies) :mortality in the catastrophic antiphospholipid syndrome: causes of death and prognostic factors in a series of 250 patients. Arthritis Rheum 54:2568-2576
26. Cervera R, Piette JC, Font J et al (2002) Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1, 000 patients. Arthritis Rheum 46:1019-1027
27. Asherson RA, Cervera R, Piette JC et al (1998) Catastrophic antiphospholipid syndrome: clinical and laboratory features of 50 patients. Medicine (Baltimore) 77:195-207
28. Dentali F, Crowther M (2010) Antiphospholipid antibodies in critical illness. Crit Care Med 38(Suppl 2):S51-S56
29. Kitchens CS (1998) Thrombotic storm: when thrombosis begets thrombosis. Am J Med 104:381-385
30. Meroni PL (2008) Pathogenesis of the antiphospholipid syndrome: an additional example of the mosaic of the autoimmunity. J Autoimmun 30:99-103
31. Espinosa G, Cervera R (2009) Morbidity and mortality in the antiphosholipid syndrome. Curr Opin Pulm Med 15:413-417
32. Hudson M, Herr AL, Rauch J et al (2003) The presence of multiple prothrombotic risk factors is associated with a higher risk of thrombosis in individuals with anticardiolipin antibodies. J Rheumatol 30:2385-2391
33. Schulman S, Svenungsson E, Granqvist S (1998) Duration of Anticoagulation Study Group: anticardiolipin antibodies predict early recurrence of thromboembolism and death among patients with venous thromboembolism following anticoagulant therapy. Am J Med 104:332-338
34. Kearon C, Gent M, Hirsh J et al (1999) A comparison of three month of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism. N Engl J Med 340:901-907
35. Kearon C, Ginsberg JS, Kovacs MJ et al (2003) Comparison of low-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism. N Engl J Med 349:631-639
36. Rosove MH, Brewer PM (1992) Antiphospholipid thrombosis: clinical course after the first thrombotic event in 70 patients. Ann Intern Med 117:303-308
37. Khamashta MA, Cuadrato MJ, Mujic F et al (1995) The management of thrombosis in the antiphospholipid-antibody syndrome. N Engl J Med 332:993-997
38. Finazzi G, Brancaccio V, Moia M et al (1996) Natural history and risk factors for thrombosis in 360 patients with antiphospholipid antibodies: a four years prospective study from the Italian Registry. Am J Med 100:530-536
39. Tsapanos V, Kanellopoulos N, Cardamakis E et al (2000) Anticardiolipin antibodies level in healthy pregnant and non-pregnant women. Arch Gynecol Obstet 263:111-115
40. Oshiro BT, Silver RM, Scott JR et al (1996) Antiphospholipid antibodies and fetal death. Obstet Gynecol 87:489-493
41. Rai RS, Clifford K, Cohen H et al (1995) High prospective fetal loss rate in untreated pregnancies of women with recurrent miscarriage and antiphospholipid antibodies. Hum Reprod 10:3301-3304
42. Branch DW, Silver RM, Blackwell JL, Reading JC, Scott JR (1992) Outcome of treated pregnancies in women with antiphospholipid syndrome: an update of the Utah experience. Obstet Gynecol 80:614-620
43. Out HJ, Bruinse HW, Christiens GC et al (1992) A prospective, controlled, multicenter study on the obstetric risk in pregnant women with antiphospholipid antibodies. Am J Obstet Gynecol 167:26-32
44. Buller HR, Agnelli G, Hull RD et al (2004) Antithrombotic therapy for venous thromboembolic disease: the seventh ACCP conference on antithrombotic and thrombolitic therapy. Chest 126:401S-428S
45. Garcia DA, Khamashta MA, Crowther MA (2007) How we diagnose and treat thrombotic manifestations of the antiphospholipid syndrome: a case-based review. Blood 110:3122-3127
46. Crowther MA, Ginsberg JS, Julian J et al (2003) A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome. N Engl J Med 349:1133-1138
47. Finazzi G, Marchioli R, Brancaccio V et al (2005) A randomized clinical trial of highintensity warfarin vs conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome (WAPS). J Thromb Haemost 3:848-853
48. Tenedios F, Erkan D, Lockshin MD (2005) Cardiac involvement in the antiphospholipid syndrome. Lupus 14:691-696
49. The APASS Writing Committee (2004) Antiphospholipid antibodies and subsequent thrombo-occlusive events in patients with ischemic stroke. JAMA 2004 291:576-584
50. Mohr JP, Thompson JL, Lazar RM et al (2001) A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke. N Engl J Med 345:1444-1451
51. Brey RL, Chapman J, Levin SR et al (2003) Stroke and antiphospholipid syndrome: consensus meeting Taormina 2002. Lupus 12:508-513
52. Okuma H, Kitagawa Y, Yasuda T et al (2009) Comparison between single antiplatelet therapy and combination of antiplatelet and anticoagulation therapy for secondary prevention in ischemic stroke patients with antiphospholipid syndrome. Int J Med Sci 7:15-18
53. Alagorn-Segovia D, Boffa MC, Branch W et al (2003) Prophylaxis of the antiphospholipid syndrome: a consensus report. Lupus 12:499-503
54. Erkan D, Harrison MJ, Levi R et al (2007) Aspirin for primary thrombosis prevention in the antiphospholipid syndrome: a randomized, double-bind, placebo-controlled trial in asymptomatic antiphospholipid antibody-positive individuals. Arthritis Rheum 56:2382-2391
55. Vivaldi P, Rossetti G, Galli M, Finazzi G (1997) Severe bleeding due to acquired hypoprothrombinemia-lupus anticoagulant syndrome. Case report and review of literature. Haematologica 82:345-347